Cisplatin and Claforan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cisplatin (cisplatin) and Claforan (cefotaxime sodium). Common drug interactions include pyelonephritis among females and cystitis escherichia among males.

The phase IV clinical study analyzes what interactions people have when they take Cisplatin and Claforan. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Claforan?

Claforan has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,527 Claforan users. Check the latest studies of Claforan.



On Jul, 16, 2026

11 people who take Cisplatin and Claforan together, and have interactions are studied.

Cisplatin and Claforan drug interactions.

What are the common drug interactions of Cisplatin and Claforan, by gender? *:

female:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
  5. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  6. Depressed level of consciousness
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Fungal infection
  9. Haemorrhage (bleeding)
  10. Hypotension (abnormally low blood pressure)

male:

  1. Cystitis escherichia (inflammation of the wall of the bladder by bacteria escherichia coli)
  2. Dehydration (dryness resulting from the removal of water)
  3. Erythema (redness of the skin)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Lung adenocarcinoma (a form of non-small cell lung cancer)
  6. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Pneumonia

What are the common drug interactions of Cisplatin and Claforan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)

20-29:

n/a

30-39:

n/a

40-49:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
  3. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  4. Depressed level of consciousness
  5. Fungal infection
  6. Haemorrhage (bleeding)
  7. Hypotension (abnormally low blood pressure)
  8. Lung disorder (lung disease)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Pleural effusion (water on the lungs)

50-59:

n/a

60+:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Erythema (redness of the skin)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Lung adenocarcinoma (a form of non-small cell lung cancer)
  8. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  9. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Cervix Carcinoma (cancer of cervix): 3 people, 27.27%
  2. Desmoplastic Small Round Cell Tumor: 2 people, 18.18%
  3. Pneumonia: 1 person, 9.09%
  4. Neoplasm Malignant (cancer tumour): 1 person, 9.09%
  5. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 9.09%
  6. Dyspnea (difficult or laboured breathing): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and Claforan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cisplatin and Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claforan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cisplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claforan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cisplatin and cefotaxime sodium (the active ingredients of Cisplatin and Claforan, respectively), and Cisplatin and Claforan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: